Renalytix plc (RNLX) Financials

RNLX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 11.3 million 19.2 million
2023-09-30 19.5 million 21.0 million
2023-06-30 30.6 million 23.7 million
2023-03-31 30.6 million 23.7 million

RNLX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.9 million 97000
2023-09-30 -9.5 million 523000
2023-06-30 -8.6 million 574000
2023-03-31 -8.6 million 574000

RNLX Net Income

No data available :(

RNLX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.6 million - 118000
2023-09-30 13.9 million - 141000
2023-06-30 - - 171000
2023-03-31 24.7 million - 200000

RNLX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48.6 million
2023-09-30 47.4 million
2023-06-30 93.8 million
2023-03-31 46.9 million

RNLX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 3.2 million 2.2 million 3.1 million
2023-09-30 - 2.8 million 6.1 million -
2023-06-30 - 3.3 million 6.5 million -
2023-03-31 - 3.3 million 6.5 million -

RNLX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 709000 480000
2023-09-30 459000 502000
2023-06-30 518000 673000
2023-03-31 518000 673000

RNLX

Price: $0.67

52 week price:
0.25
4.04

Earnings Per Share: -0.90 USD

P/E Ratio: -0.79

Exchange: NGM

Sector: Healthcare

Industry: Health Information Services

Volume: 137500

Market Capitalization: 51.8 million

Links: